| Features: |
| Echistatin is a small disintegrin peptide originally isolated from Echis carinatus (saw-scaled viper) venom. It contains an RGD (Arg-Gly-Asp) integrin-binding motif and acts as a potent antagonist of RGD-binding integrins, particularly αvβ3, αIIbβ3, αvβ5 and α5β1. By disrupting integrin-mediated adhesion and signalling, echistatin can inhibit tumour-cell attachment, migration, invasion, proliferation and angiogenesis. Preclinical cancer studies have shown inhibition of tumour growth and pulmonary metastasis, particularly in αvβ3-overexpressing osteosarcoma models, and echistatin has also inhibited migration of melanoma, glioblastoma and pancreatic cancer cells. Its anticancer activity is therefore primarily associated with integrin antagonism, especially αvβ3 inhibition. Echistatin is classified as an experimental peptide/disintegrin rather than as a natural supplement, and current anticancer evidence is predominantly preclinical. |
| Source: |
| Type: |
| Antiplatelet aggregation refers to the process by which platelets clump together to form a blood clot. The plethora of evidence indicates that among multiple hemostasis components, platelets play major roles in cancer progression by providing surface and granular contents for several interactions as well as behaving like immune cells.On the other hand, there are suggestions that antiplatelet treatment may promote solid tumor development in a phenomenon described as “cancers follow bleeding.” The controversies around antiplatelet agents justify insight into the subject to establish what, if any, role platelet-directed therapy has in the continuum of anticancer management. The interplay between antiplatelet aggregation and cancer is an area of active research, with potential implications for therapeutic strategies. Antiplatelet agents, such as aspirin, are being investigated for their role in cancer prevention and treatment, particularly in reducing metastasis and improving patient outcomes. |
| 7147- | RES, | EGCG, | GEN, | Echi, | FIS | Antithrombotic effects of naturally derived products on coagulation and platelet function |
| - | Review, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:431 Target#:10 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid